- Drugs
- Tuesday, 07 Jan 2020
Harvest Files Suit Against Falcon International, Inc.
Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HRVSF) ("Harvest"), a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., announced that yesterday Harvest filed suit against Falcon International, Inc. ("Falcon") requesting termination and rescission of the Merger Agreement ("Transaction") and return of money Harvest paid to Falcon under the Merger Agreement. As detailed in the Complaint, filed in U.S. Federal Court, District of Arizona, Harvest alleges that Falcon has failed to meet its legal obligations in multiple ways, including the failure to provide auditable financial records, which precludes Harvest from moving forward with the Transaction.
While Harvest remains committed to the long-term potential of legal cannabis sales in California, current market conditions make it difficult to operate profitably there today. If the Transaction does not close for any reason, including those enumerated in the Complaint, the company plans to remove the contribution attributable to Falcon from its 2020 pro forma guidance. Harvest expects overall 2020 pro forma profitability would improve without the revenue contribution from Falcon.
Related Industry Updates
Neurotoxin Market is expected to reach US$ 13,195.06 million by 2028
May 09, 2023
Luye Pharma Submits New Drug Application in the U.S. for Its Antidepressant Drug LY03005
Dec 27, 2019
Tiamulin Market Trends, Strong Application Scope, Key Players, Growth Overview and Forecast by 2027
Mar 23, 2021
Former Deputy Head of China's Drug Regulator Sentenced to 16 Years in Prison
Nov 15, 2019
Allergan Foundation Giving Reaches $95 Million Since Inception
Dec 19, 2019
FDA Approves BYSANTI™ (milsaperidone) for Bipolar I and Schizophrenia
Feb 23, 2026
NORTH AMERICA DRY EYE PRODUCT MARKET IS ANTICIPATED TO GROW WITH A CAGR OF 5.0% FROM 2019 TO 2027 , according to Business Market Insights
Jan 28, 2021